Cargando…

TREK channels in Mechanotransduction: a Focus on the Cardiovascular System

Mechano-electric feedback is one of the most important subsystems operating in the cardiovascular system, but the underlying molecular mechanism remains rather unknown. Several proteins have been proposed to explain the molecular mechanism of mechano-transduction. Transient receptor potential (TRP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrera-Pérez, Salvador, Lamas, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242076/ https://www.ncbi.nlm.nih.gov/pubmed/37288256 http://dx.doi.org/10.3389/fcvm.2023.1180242

Ejemplares similares

Ion Channels and Thermosensitivity: TRP, TREK, or Both?
por: Lamas, J. Antonio, et al.
Publicado: (2019)

Are TREK Channels Temperature Sensors?
por: Rueda-Ruzafa, Lola, et al.
Publicado: (2021)

Contribution of KCNQ and TREK Channels to the Resting Membrane Potential in Sympathetic Neurons at Physiological Temperature
por: Rivas-Ramírez, Paula, et al.
Publicado: (2020)

Mechanotransduction in Coronary Vein Graft Disease
por: Ruiter, Matthijs Steven, et al.
Publicado: (2018)

Antiarrhythmic calcium channel blocker verapamil inhibits trek currents in sympathetic neurons
por: Herrera-Pérez, S., et al.
Publicado: (2022)

Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis
por: Pagnozzi, Leah A., et al.
Publicado: (2017)

PIP(2) Mediated Inhibition of TREK Potassium Currents by Bradykinin in Mouse Sympathetic Neurons
por: Rivas-Ramírez, Paula, et al.
Publicado: (2020)

Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers
por: Kim, Eun-Jin, et al.
Publicado: (2017)

Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons
por: Fernández-Fernández, Diego, et al.
Publicado: (2018)

The Kv7 Channel and Cardiovascular Risk Factors
por: Fosmo, Andreas L., et al.
Publicado: (2017)

The Intersection of Diabetes and Cardiovascular Disease—A Focus on New Therapies
por: Dhindsa, Devinder S., et al.
Publicado: (2018)

Targeting Lipid—Ion Channel Interactions in Cardiovascular Disease
por: Hudgins, Emma C., et al.
Publicado: (2022)

β subunits of voltage-gated calcium channels in cardiovascular diseases
por: Loh, Kelvin Wei Zhern, et al.
Publicado: (2023)

Behavioral characterization of mice lacking Trek channels
por: Mirkovic, Kelsey, et al.
Publicado: (2012)

Role of TREK-1 in Health and Disease, Focus on the Central Nervous System
por: Djillani, Alaeddine, et al.
Publicado: (2019)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

TREK channel activation suppresses migraine pain phenotype
por: Ávalos Prado, Pablo, et al.
Publicado: (2021)

Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease
por: Byrne, Paula, et al.
Publicado: (2018)

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death
por: Antoniak, Silvio, et al.
Publicado: (2022)

Editorial: Multicellularity in the Cardiovascular System
por: Madeddu, Paolo, et al.
Publicado: (2019)

Associations of ATP-Sensitive Potassium Channel’s Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes
por: Liu, Cheng, et al.
Publicado: (2022)

Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect
por: Du, Yao, et al.
Publicado: (2022)

Effect of alirocumab and evolocumab on all-cause mortality and major cardiovascular events: A meta-analysis focusing on the number needed to treat
por: Wang, Hong-Fei, et al.
Publicado: (2022)

Editorial: The Serpin Family in the Cardiovascular System
por: Bouton, Marie-Christine, et al.
Publicado: (2022)

Mechanisms of Cardiovascular System Injury Induced by COVID-19 in Elderly Patients With Cardiovascular History
por: Yang, Yaliu, et al.
Publicado: (2022)

The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
por: Cunningham, Kevin P., et al.
Publicado: (2021)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

Cardiovascular health control in the family health strategy
por: Tavares, Gilberto Andrade, et al.
Publicado: (2022)

While you’re waiting, a waiting room-based, cardiovascular disease-focused educational program: protocol for a randomised controlled trial
por: Mcintyre, Daniel, et al.
Publicado: (2020)

Systems Medicine as an Emerging Tool for Cardiovascular Genetics
por: Haase, Tina, et al.
Publicado: (2016)

Heterocellularity and Cellular Cross-Talk in the Cardiovascular System
por: Perbellini, Filippo, et al.
Publicado: (2018)

Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
por: Glynn, Peter, et al.
Publicado: (2022)

Role of Catestatin in the Cardiovascular System and Metabolic Disorders
por: Zalewska, Ewa, et al.
Publicado: (2022)

Up-Regulation of TREK-2 Potassium Channels in Cultured Astrocytes Requires De Novo Protein Synthesis: Relevance to Localization of TREK-2 Channels in Astrocytes after Transient Cerebral Ischemia
por: Rivera-Pagán, Aixa F., et al.
Publicado: (2015)

Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator
por: Joseph, Ancy, et al.
Publicado: (2018)

The role of digital health in the cardiovascular learning healthcare system
por: Maddula, Ragasnehith, et al.
Publicado: (2022)

Sodium channels and mammalian sensory mechanotransduction
por: Raouf, Ramin, et al.
Publicado: (2012)

Physics of mechanotransduction by Piezo ion channels
por: Young, Michael, et al.
Publicado: (2022)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
por: Masbuchin, Ainun Nizar, et al.
Publicado: (2022)

Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0toclv66vg17b1i70qla9vng77